Table 2A.
Category | Term | Count | P Value |
---|---|---|---|
BP | Nitrobenzene metabolic process | 4 | 5.72E-05 |
BP | Glutathione derivative biosynthetic process | 6 | 1.60E-04 |
BP | Cochlea development | 6 | 2.48E-04 |
BP | Metabolic process | 14 | 2.57E-04 |
BP | Negative regulation of neuron apoptotic process | 12 | 4.04E-04 |
CC | Extracellular space | 61 | 2.16E-06 |
CC | Plasma membrane | 140 | 4.21E-06 |
CC | Proteinaceous extracellular matrix | 20 | 2.60E-05 |
CC | Integral component of plasma membrane | 55 | 4.32E-04 |
CC | Cell surface | 27 | 6.50E-04 |
MF | Protein homodimerization activity | 38 | 1.81E-05 |
MF | Calcium ion binding | 36 | 6.59E-05 |
MF | Glutathione binding | 5 | 9.70E-05 |
MF | Glutathione transferase activity | 7 | 1.72E-04 |
MF | Phospholipase A2 inhibitor activity | 3 | 3.39E-03 |
BP: biological process; CC: cellular component; MF: molecular function.